I have not posted for some time. I hope you are progressing on a good track as you go down the path of PC progress and treatments.
I now have advanced, metastatic, castrate resistant prostrate cancer.
My treatments have included the typical stages of a rising PSA, positive biopsy (T2C, 3+3) diagnoses, radiation treatments, hormone treatments, Vantas implant, etc....
After all treatments have failed, I was left with the two "standard of care" options of either Chemo or Radium. Both of these options are very toxic to the body and very difficult to tolerate. Also, as you probably know, these treatments are not going to "cure" the prostate cancer, only meant to try to slow down the inevitable and hopefully keep things under control for some time.
I was lucky that my Oncologist was
open to looking into all available clinical trials. After some research, he found two clinical trials that looked to hold out some potential promise. The first is a immunotherapy and the second is a DNA marker therapy to correct defective genes.
I subsequently performed the approval process to see if I could be a candidate for either of these clinical trials. I have been screened for both and have been accepted to both. At this point I have decided to start the immunotherapy clinical trial, but as I have qualified for the DNA clinical trial, I have the option to roll over to that clinical trial if there are any issues staying in the first clinical trial.
I am about
two weeks into the immunotherapy trial, and therefore there is still no way to know if there is going to be any benefit yet or not. That will take some time, possibly months in the future.
Both of these clinical trials are not toxic to the body, and most participants are able to tolerate the treatments with little, or no side-effects.
I am excited about
the potential behind the immunotherapy clinical trial. They have had some very positive results, including full remission. The immunotherapy "reactivates" the T-Cels in your immune system that the cancer has determined how to turn off, and therefore allows your own immune system to start attacking the cancer again.
This clinical trial will have ~170 participants nationally, but at Duke Cancer Center, in Durham, NC, there will only be 25 participants. I am number 16.
I will try to keep you posted on my progress.
Post Edited (tedgard) : 8/21/2018 4:16:49 PM (GMT-6)